Feasibility study of mindfulness-based cognitive therapy for anxiety disorders in a Japanese setting

Sado, Mitsuhiro; Park, Sunre; Ninomiya, Akira; Sato, Yasuko; Fujisawa, Daisuke; Shirahase, Joichiro; Mimura, Masaru

doi:10.1186/s13104-018-3744-4

BMC Research Notes

Table 3 Outcomes scores at each assessment point with comparison to baseline

From: Feasibility study of mindfulness-based cognitive therapy for anxiety disorders in a Japanese setting

Mean score at baseline and mean differences compared to baseline
	n	Baseline		4 week		8 week		12 week		16 week
	n	Mean	se	Mean difference	se	Mean difference	se	Mean difference	se	Mean difference	se
STAI-state	14	52.6	2.8	− 6.14	2.70	− 11.66	2.78	− 8.12	2.78	− 6.58	2.78
P value	14	52.6	2.8	0.02		< 0.001		< 0.01		0.02
STAI-trait	14	55.9	3.0	− 3.86	1.85	− 6.55	1.90	− 4.86	1.90	− 3.93	1.90
P value	14	55.9	3.0	0.04		< 0.01		0.01		0.04
K-6	14	8.6	1.6	− 1.07	1.17	− 2.68	1.20	− 1.68	1.20	0.16	1.20
P value	14	8.6	1.6	0.36		0.03		0.16		0.89
CESD	14	17.7	3.0	− 0.71	2.03	− 1.46	2.09	− 3.85	2.09	1.69	2.09
P value	14	17.7	3.0	0.73		0.48		0.07		0.42
SF36 PCS	14	54.1	2.8	− 0.57	2.02	1.68	2.07	0.52	2.07	1.32	2.07
P value	14	54.1	2.8	0.78		0.42		0.80		0.53
SF36MCS	14	41.4	3.6	− 2.17	2.18	2.11	2.25	2.27	2.25	− 1.33	2.25
P value	14	41.4	3.6	0.32		0.35		0.31		0.55
SF36 RCS	14	42.5	4.3	3.13	2.84	3.03	2.92	4.50	2.92	2.29	2.92
P value	14	42.5	4.3	0.27		0.30		0.12		0.43
FFMQ (total)	14	110.4	4.9	− 1.42	2.25	2.51	2.31	0.96	2.31	− 1.17	2.31
P value	14	110.4	4.9	0.53		0.28		0.68		0.61
FFMQ (observe)	14	22.6	1.5	− 0.93	0.99	0.07	1.01	0.14	1.01	0.77	1.01
P value	14	22.6	1.5	0.35		0.94		0.89		0.45
FFMQ (noreact)	14	16.6	1.7	− 0.79	0.84	0.93	0.87	0.81	0.87	0.39	0.87
P value	14	16.6	1.7	0.35		0.28		0.35		0.65
FFMQ (nonjudgement)	14	23.9	2.0	2.00	1.17	2.62	1.21	2.54	1.21	0.77	1.21
P value	14	23.9	2.0	0.09		0.03		0.04		0.52
FFMQ (descrive)	14	22.9	1.5	− 1.18	0.84	0.57	0.87	− 0.96	0.87	− 1.04	0.87
P value	14	22.9	1.5	0.16		0.51		0.27		0.23
FFMQ (awareness)	14	24.5	1.6	− 0.52	1.11	− 1.69	1.15	− 1.58	1.15	− 2.07	1.15
P value	14	24.5	1.6	0.64		0.14		0.17		0.07
EQ-5D	14	0.79	0.04	0.01	0.03	0.02	0.03	0.03	0.03	0.04	0.03
P value	14	0.79	0.04	0.79		0.41		0.22		0.09
MIA (AAC)	6	1.88	0.29	− 0.08	0.09	− 0.18	0.09	− 0.13	0.09	− 0.24	0.09
P value	6	1.88	0.29	0.39		0.05		0.14		< 0.01
MIA (AAL)	6	2.24	0.49	− 0.02	0.14	− 0.15	0.14	− 0.05	0.14	− 0.25	0.14
P value	6	2.24	0.49	0.87		0.28		0.71		0.07
MIA (panic attack 1 weeks)	6	2.83	2.44	− 0.17	1.19	− 1.67	1.19	− 2.17	1.19	− 1.67	1.19
P value	6	2.83	2.44	0.89		0.16		0.07		0.16
MIA (panic attack 3 weeks)	6	5.83	4.85	− 1.00	1.72	− 3.33	1.72	− 2.83	1.72	− 2.50	1.72
P value	6	5.83	4.85	0.56		0.05		0.10		0.15
LSAS	5	73.40	13.41	− 12.00	6.81	− 3.63	7.42	− 7.38	7.42	− 9.13	7.42
P value	5	73.40	13.41	0.08		0.63		0.32		0.22

Back to article page

ISSN: 1756-0500

Contact us

Submission enquiries: bmcresearchnotes@biomedcentral.com
General enquiries: ORSupport@springernature.com